Next-generation POC Devices for Western and Global Health Markets

Video   Jul 21, 2015

 



About the Speaker
Samuel Sia is an Associate Professor in the Department of Biomedical Engineering at Columbia University. His lab focuses on using microfluidics for global health diagnostics and for 3D tissue biology. He is a founder of Claros Diagnostics, a venture capital-backed company developing diagnostics products which was acquired by Opko Health, and Harlem Biospace, New York City's first life-science incubatorAbstract
Portable diagnostic devices have a tremendous potential for revolutionizing personal health.  In U.S. and Europe, patients and consumers can have greater access to traditionally complex diagnostics, and in developing countries, mobile diagnostics provides immediate diagnosis in the field.  We will discuss our lab's current efforts in these areas, in conjunction with partners in industry, public health, and local governments.  Our tests span a variety of technologies, and target HIV, sexually transmitted diseases, and chronic diseases.

 
 

Recommended Videos

Tracking Cancer With A Blood Test

Video

Blood tests that fish for either tumour DNA or cancer cells in patient blood samples are showing great promise. This type of blood analysis is helping Cancer Research UK scientists and doctors better understand the biology of cancer from its earliest origins to when it spreads around the body.

WATCH NOW

Here’s What We Learned From 83,000 Brain Scans

Video

The most important lesson from 83,000 brain scans.

WATCH NOW

Company Incorporates Pregnancy Test into Magazine Advert

Video

Mercene Labs has developed a very large pregnancy test integrated in a printed advertisement for IKEA. The finished ad appeared in the Swedish women’s magazine Amelia.

WATCH NOW

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE